装甲型多菌素B:一种用于对抗多药物耐药的格拉姆阴性细菌的纳米系统
Jianling Huang1, Xiuwen Hong2, Yunxiang Lv1
1Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Bengbu Medical University, Anhui Clinical and Preclinical Key Laboratory of Respiratory Disease, Molecular Diagnosis Center Bengbu Anhui 233000 China huang021706@163.com.
RSC advances
|December 18, 2024
概括
一种新的纳米药物输送系统有效地向由多药耐药细菌引起的肺部感染. 这种仿生方法增强了Polymyxin B的输送,改善了治疗结果,并减少了细菌感染的毒性.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 传染性疾病 传染性疾病
背景情况:
- 细菌感染,特别是由多药耐药 (MDR) 菌株引起的细菌感染,对全球健康构成重大威胁.
- 聚米辛B (PMB) 是治疗格拉姆阴性细菌感染的关键抗生素,但由于肺透性差以及剂量依赖性毒性,它面临着局限性.
研究的目的:
- 开发一个有针对性的纳米药物输送系统,以提高Polymyxin B在治疗MDR细菌性肺炎的疗效和安全性.
- 评估一种新型仿生纳米载体对抗肺部感染的治疗潜力.
主要方法:
- 一个向的纳米药物输送系统,PMB@HMnO2@NM,是使用与中性粒细胞膜覆盖的空洞中性孔二氧化纳米粒子进行工程设计的.
- 该系统的有效性被评估在一个小鼠模型的急性肺炎诱导多药耐药性*Pseudomonas aeruginosa*.
主要成果:
- PMB@HMnO2@NM证明了针对细菌聚合物和感染的肺组织的向传递.
- 与自由的PMB相比,纳米药物配方显著提高了生存率并减少了肺炎.
- 在纳米药物治疗中没有观察到显著的毒性或神经毒性.
结论:
- PMB@HMnO2@NM纳米药物输送系统为增强MDR细菌感染,特别是肺炎的治疗提供了一个有希望的策略.
- 仿生纳米载体可以克服传统抗生素的局限性,为开发下一代抗菌疗法提供基础.
相关概念视频
01:27Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...